Intrinsic tolerance in autologous collagen-induced arthritis is generated by CD152-dependent CD4+ suppressor cells

Journal of Immunology

Volumn 174, Issue 11, 2005, Pages 6742-6750

  Treschow, Alexandra P ^a   Bäcklund, Johan ^a   Holmdahl, Rikard ^a   Issazadeh Navikas, Shohreh ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SUPPRESSOR CELL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 18944377933     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.11.6742     Document Type: Article

References (55)

1. Courtenay, J. S., M. J. Dallman, A. D. Dayan, A. Martin, and B. Mosedale. 1980. Immunisation against heterologous type 11 collagen induces arthritis in mice. Nature 283: 666-668.
2. Wooley, P. H., H. S. Luthra, J. M. Stuart, and C. S. David. 1981. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 154: 688-700.
3. Brunsberg, U., K. Gustafsson, L. Jansson, E. Michaëlsson, L. Ahrlund-Richter, S. Pettersson, R. Mattsson, and R. Holmdahl. 1994. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur. J. Immunol. 24: 1698-1702.
4. Corthay, A., A. Johansson, M. Vestberg, and R. Holmdahl. 1999. Collagen-induced arthritis development requires αβ T cells but not γδ T cells: studies with T cell-deficient (TCR mutant) mice. Int. Immunol. 11: 1065-1073.
5. Corthay, A., J. Bäcklund, J. Broddefalk, E. Michaëlsson, T. J. Goldschmidt, J. Kihlberg, and R. Holmdahl. 1998. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur. J. Immunol. 28: 2580-2590.
6. Ap molecules. Eur. J. Immunol. 28: 755-766.
7. Bäcklund, J., S. Carlsen, T. Hoger, B. Holm, L. Fugger, J. Kihlberg, H. Burkhardt, and R. Holmdahl. 2002. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 99: 9960-9965.
8. Weiner, H. L., A. Friedman, A. Miller, S. J. Khoury, A. al-Sabbagh, L. Santos, M. Sayegh, R. B. Nussenblatt, D. E. Trentham, and D. A. Hafler. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12: 809-837.
9. Myers, L. K., J. M. Stuart, and A. H. Kang. 1989. A CD4 cell is capable of transferring suppression of collagen-induced arthritis. J. Immunol. 143: 3976-3980.
10. Malmstrom, V., E. Michaëlsson, H. Burkhardt, R. Mattsson, E. Vuorio, and R. Holmdahl. 1996. Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc. Natl. Acad. Sci. USA 93: 4480-4485.
11. Malmstrom, V., J. Bäcklund, L. Jansson, J. Kihlberg, and R. Holmdahl. 2000. T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis. Arthritis Res. 2: 315-326.
12. Karandikar, N. J., C. L. Vanderlugt, T. L. Walunas, S. D. Miller, and J. A. Bluestone. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184: 783-788.
13. Luhder, F., P. Hoglund, J. P. Allison, C. Benoist, and D. Mathis. 1998. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187: 427-432.
14. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3: 541-547.
15. Issazadeh, S., M. Zhang, M. H. Sayegh, and S. J. Khoury. 1999. Acquired thymic tolerance: role of CTLA4 in the initiation and maintenance of tolerance in a clinically relavant autoimmune disease model. J. Immunol. 162: 761-765.
16. Perez, V. L., L. Van Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6: 411-417.
17. Samoilova, E. B., J. L. Horton, H. Zhang, S. J. Khoury, H. L. Weiner, and Y. Chen. 1998. CTLA-4 is required for the induction of high dose oral tolerance. Int. Immunol. 10: 491-498.
18. Milicic, A., M. A. Brown, and B. P. Wordsworth. 2001. Polymorphism in codon 17 of the CTLA-4 gene (+49 A/G) is not associated with susceptibility to rheumatoid arthritis in British Caucasians. Tissue Antigens 58: 50-54.
19. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192: 303-310.
20. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182: 18-32.
21. Sakaguchi, S., T. Takahashi, S. Yamazaki, Y. Kuniyasu, M. Itoh, N. Sakaguchi, and J. Shimizu. 2001. Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: implications for autoimmunity and rumor immunity. Microbes Infect. 3: 911-918.
22. Cobelens, P. M., A. Kavelaars, R. van der Zee, W. van Eden, and C. J. Heijnen. 2002. Dynamics of mycobacterial HSP65-induced T-cell cytokine expression during oral tolerance induction in adjuvant arthritis. Rheumatology 41: 775-779.
23. Smith, B. D., G. R. Martin, E. J. Miller, A. Dorfman, and R. Swarm. 1975. Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch. Biochem. Biophys. 166: 181-186.
24. Andersson, M., and R. Holmdahl. 1990. Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur. J. Immunol. 20: 1061-1066.
25. Broddefalk, J., J. Bäcklund, F. Almqvist, M. Johansson, R. Holmdahl, and J. Kihlberg. 1998. T cells recognize a glycopeptide derived from type II collagen in a model for rheumatoid arthritis. J. Am. Chem. Soc. 120: 7676-7683.
26. Michaëlsson, E., M. Andersson, A. Engstrom, and R. Holmdahl. 1992. Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur. J. Immunol. 22: 1819-1825.
27. Svensson, L., J. Jirholt, R. Holmdahl, and L. Jansson. 1998. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin. Exp. Immunol. 111: 521-526.
28. Holmdahl, R., S. Carlsen, A. Mikulowska, M. Vestberg, U. Brunsberg, A. Hansson, M. Sundvall, L. Jansson, and U. Pettersson. 1998. Genetic Analysis of Mouse Models for Rheumatoid Arthritis. CRC Press, New York.
29. Holmdahl, R., L. Klareskog, M. Andersson, and C. Hansen. 1986. High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics 24: 84-89.
30. + regulatory T cells. Eur. J. Immunol. 32: 1621-1630.
31. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
32. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
33. + regulatory T cells. J. Immunol. 170: 3939-3943.
34. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306.
35. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162: 5317-5326.
36. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167: 188-195.
37. + T cells. Microbes Infect. 3: 919-927.
38. Malmstrom, V., P. Kjellen, and R. Holmdahl. 1998. Type II collagen in cartilage evokes peptide-specific tolerance and skews the immune response. J. Autoimmun. 11: 213-221.
39. + cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 48: 1452-1460.
40. + regulatory T cells: implications of their broad repertoire and high self-reactivity for the maintenance of immunological self-tolerance. Novartis Found Symp. 252: 6-16.
41. Lovell-Badge, R. H., A. Bygrave, A. Bradley, E. Robertson, R. Tilly, and K. S. Cheah. 1987. Tissue-specific expression of the human type II collagen gene in mice. Proc. Natl. Acad. Sci. USA 84: 2803-2807.
42. Dzhambazov, B., M. Holmdahl, H. Yamada, S. Lu, M. Vestberg, B. Holm, O. Johnell, J. Kihlberg, and R. Holmdahl. 2005. The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans. Eur. J. Immunol. 35: 357-366.
43. Backhand, J., K. S. Nandakumar, R. Bockermann, L. Mori, and R. Holmdahl. 2003. Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model. J. Immunol. 171: 3493-3499.
44. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
45. Prakken, B. J., S. Roord, P. J. van Kooten, J. P. Wagenaar, W. van Eden, S. Albani, and M. H. Wauben. 2002. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. Arthritis Rheum. 46: 1937-1946.
46. Johansson, A. C., A.-S. Hansson, K. S. Nandakumar, J. Bäcklund, and R. Holmdahl. 2001. IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies. J. Immunol. 167: 3505-3512.
47. Fowler, S., and F. Powrie. 2002. CTLA-4 expression on antigen-specific cells but not IL-10 secretion is required for oral tolerance. Eur. J. Immunol. 32: 2997-3006.
48. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183: 2533-2540.
49. Brunner, M. C., C. A. Chambers, F. K.-M. Chan, J. Hanke, A. Winoto, and J. P. Allison. 1999. CTLA-4-mediated inhibition of early events of T cell proliferation. J. Immunol. 162: 5813-5820.
50. Lee, K.-M., E. Chuang, M. Griffin, R. Khattri, D. K. Hong, W. Zhang, D. Straus, L. E. Samelson, C. B. Thompson, and J. A. Bluestone. 1998. Molecular basis of T cell inactivation by CTLA-4. Science 282: 2263-2266.
51. + T cells. J. Exp. Med. 188: 1849-1857.
52. Sullivan, T. J., J. J. Letterio, A. van Elsas, M. Mamura, J. van Amelsfort, S. Sharpe, B. Metzler, C. A. Chambers, and J. P. Allison. 2001. Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation. Proc. Natl. Acad. Sci. USA 98: 2587-2592.
53. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192: 303-310.
54. Chai, J.-G., S. Vendetti, E. Amofah, J. Dyson, and R. Lechier. 2000. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation. J. Immunol. 165: 3037-3042.
55. Pandiyan, P., D. Gartner, O. Soezeri, A. Radbruch, K. Schulze-Osthoff, and M. C. Brunner-Weinzierl. 2004. CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function. J. Exp. Med. 199: 831-842.